Ignite Creation Date:
2024-05-05 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00264901
Status:
COMPLETED
Last Update Posted:
2017-01-31
First Post:
2005-12-12
Brief Title:
Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
Impact of a Self-Adjusted Titration Guideline in Subjects With Type 2 Diabetes Mellitus A Treat-to-Target of the Efficacy and Safety of Levemir Insulin Detemir rDNA Origin Injection PREDICTIVE 303
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PREDICTIVE
Brief Summary:
This trial is conducted in the United States of America USA This trial aims for a comparison of the safety and efficacy in subjects with type 2 diabetes using either self titration or physician guided titration according to the local standard of care
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None